ADO 5.26% 2.0¢ anteotech ltd

diasource-ado to exhibit in paris expo 22nd-24th, page-22

  1. 8,898 Posts.
    lightbulb Created with Sketch. 1913
    At a short odds guess :- What they'll be promoting!

    "Albany, NY -- (SBWIRE) -- 06/01/2016 -- In Europe, approximately 70% of the total population suffers from vitamin D deficiency, of which barely 5-6% has undergone vitamin D testing. This indicates that the vitamin D testing market in Europe is unpenetrated and has a high potential since the market has a large patient pool. Major vendors in Europe understand the potential market scenario and are constantly investing in R&D and innovating vitamin D testing devices, and assays and kits that will provide an accurate result at low cost.

    Growing vitamin D deficiency will lead to various acute and chronic diseases such as cancer and asthma if not detected at an early stage and can be fatal for a patient. Thus, prevention of these fatal diseases is considered one of the major drivers contributing to the growth of the vitamin D testing market in Europe. Technavio expects the vitamin D testing market in Europe to grow at a steady rate, posting a CAGR of more than 5% during the forecast period.

    Segmentation of the vitamin D testing market in Europe by application
    - 25-hydroxy vitamin D test
    - 1, 25-dihydroxy vitamin D test

    With a massive share of 77% in 2014, the 25-hydroxy vitamin D test segment held the majority of the vitamin D testing market in Europe, and this trend is expected to continue during the forecast period. The 25-hydroxy test is the most commonly used test to detect levels of vitamin D in the body.

    Competitive landscape and key vendors

    The European market for vitamin D appears attractive from the vendors' perspective as a major part of the market is untapped. Therefore, there is robust competition among the vendors to develop products with high accuracy and efficiency through constant investment in R&D and innovation in the market.

    Top vendors in this market are -
    - Abbott Diagnostics
    - bioMerieux
    - DiaSorin
    - Fujirebio Diagnostics
    - Roche Diagnostics
    - Siemens Healthcare

    Other prominent vendors included in this report are SCIEX Diagnostics, Diazyme Laboratories, Biokit, City Assays, Tosoh Bioscience Inc., Qualigen Inc., Dade Behring, DIAsource ImmunoAssays S.A, Ortho-Clinical Diagnostics, Biorad Laboratories, Piramal Healthcare, Beckman Coulter, and Becton Dickinson."

    Read more: http://m.digitaljournal.com/pr/2959487#ixzz4BH8T8RPW
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.001(5.26%)
Mkt cap ! $49.37M
Open High Low Value Volume
2.0¢ 2.0¢ 1.9¢ $15.05K 758.4K

Buyers (Bids)

No. Vol. Price($)
4 2299968 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 209963 3
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.